A Clinically Validated Foundation Model for Comprehensive Lung Pathology Interpretation

• URL: http://arxiv.org/abs/2605.25878v1
• Date: Mon, 25 May 2026 14:04:56 GMT
• Title: A Clinically Validated Foundation Model for Comprehensive Lung Pathology Interpretation
• Abstract summary: PulmoFoundation is a prospectively validated, randomized controlled trial (RCT)-evaluated foundation model for comprehensive lung pathology assessment.<n>Our model achieves clinical-grade performance in core diagnostic tasks across biopsy, frozen section, and surgical resection slides.
• Score: 36.95302007351382
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Pathological assessment guides lung cancer diagnosis, treatment selection, and prognostic evaluation, yet current CPath approaches rely on task-specific models for isolated objectives. Although pan-cancer foundation models offer versatility, they lack subspecialty-level depth and have not been evaluated across clinical workflows or prospectively validated in real-world settings. We introduce PulmoFoundation, a multi-center, prospectively validated, randomized controlled trial (RCT)-evaluated foundation model for comprehensive lung pathology assessment across pre-operative, intra-operative, and post-operative care. Built upon Virchow2 via subspecialty-specific pretraining using ~40,000 diagnostic H&E-stained whole-slide images (WSIs), PulmoFoundation was systematically evaluated on ~26,000 WSIs across 32 clinically relevant tasks. In addition to accurately predicting molecular markers and patient survival, our model achieves clinical-grade performance in core diagnostic tasks across biopsy, frozen section, and surgical resection slides. In a registered prospective study of 1,357 patients across 11 diagnostic tasks, our model achieved an average AUC of 92.3%. Using pre-specified triage thresholds, PulmoFoundation could reduce additional second-review burden for 68.8% of biopsies and 83.0% of frozen sections, and defer 44.5% of IHC stain orders, with PPVs of 1.0, 0.991, and 0.966. Beyond prospective validation, we conducted a crossover RCT with eight pathologists, in which AI assistance improved diagnostic accuracy across 4,928 case-reader pairs (91.7% w/ AI vs. 83.8% w/o AI). AI assistance also reduced median diagnostic time by 19.6%, increased diagnostic confidence by 8.7%, and improved inter-rater agreement from moderate (kappa = 0.56) to substantial (kappa = 0.76). Together, these evaluations support PulmoFoundation as a clinically validated decision-support system for lung pathology.

Related papers

• A Pathology Foundation Model for Gastric Cancer with Real-World Validation [47.19073124722865]
  We present GRACE, a Gastric-specific foundation model for Real-world Assessment and Clinical dEcision support.<n> GRACE was developed from multicenter gastric pathology datasets totaling 48,364 primarily HE-stained whole-slide images from 37,493 patients.<n>When calibrated to maintain non-inferior performance to senior pathologists, the AI-assisted workflow could triage 60.7% of atrophy and 82.7% of intestinal metaplasia cases.
  arXiv  Detail & Related papers  (2026-06-03T12:18:06Z)
• Clinical Validation of the Melanoscope AI Mobile Dermoscopy Clinical Decision Support System [0.0]
  Early detection of malignant skin lesions is critical for prognosis.<n>Dermatologist shortages in Russian regions limit screening coverage.<n>Mobile dermoscopy clinical decision support systems offer a promising approach.
  arXiv  Detail & Related papers  (2026-05-26T18:29:53Z)
• A Breast Vision Pathology Foundation Model for Real-world Clinical Utility [65.57568187389113]
  We present bfBRAVE, a breast-adaptive pathology foundation model developed and evaluated using a total resource of 101,638 breast wholeslide images.<n>BRAVE supported practical roles in the clinical workflow, including safe exclusion of low-risk cases from routine AI-assisted second-review rescue of initially missed positives and prioritization of cases for further assessment.
  arXiv  Detail & Related papers  (2026-05-06T07:44:39Z)
• Clinician input steers frontier AI models toward both accurate and harmful decisions [10.599240857217811]
  We evaluated 21 large language models (LLMs) across 8 frontier models on differential diagnosis generation and next step recommendations.<n>Expert context significantly improved correct final diagnosis inclusion across all 21 models.<n>In GPT-4o experiments, explicit clinician uncertainty signals improved diagnostic performance after adversarial context.
  arXiv  Detail & Related papers  (2026-03-14T23:47:53Z)
• A Disease-Centric Vision-Language Foundation Model for Precision Oncology in Kidney Cancer [54.58205672910646]
  RenalCLIP is a visual-language foundation model for characterization, diagnosis and prognosis of renal mass.<n>It achieved better performance and superior generalizability across 10 core tasks spanning the full clinical workflow of kidney cancer.
  arXiv  Detail & Related papers  (2025-08-22T17:48:19Z)
• An Agentic System for Rare Disease Diagnosis with Traceable Reasoning [69.46279475491164]
  We introduce DeepRare, the first rare disease diagnosis agentic system powered by a large language model (LLM)<n>DeepRare generates ranked diagnostic hypotheses for rare diseases, each accompanied by a transparent chain of reasoning.<n>The system demonstrates exceptional diagnostic performance among 2,919 diseases, achieving 100% accuracy for 1013 diseases.
  arXiv  Detail & Related papers  (2025-06-25T13:42:26Z)
• Explainable Anatomy-Guided AI for Prostate MRI: Foundation Models and In Silico Clinical Trials for Virtual Biopsy-based Risk Assessment [3.5408411348831232]
  We present a fully automated, anatomically guided deep learning pipeline for prostate cancer (PCa) risk stratification using routine MRI.<n>The pipeline integrates three key components: an nnU-Net module for segmenting the prostate gland and its zones on axial T2-weighted MRI; a classification module based on the DiceedPT Swin Transformer foundation model, fine-tuned on 3D patches with optional anatomical priors and clinical data; and a VAE-GAN framework for generating counterfactual heatmaps that localize decision-driving image regions.
  arXiv  Detail & Related papers  (2025-05-23T14:40:09Z)
• A Clinician-Friendly Platform for Ophthalmic Image Analysis Without Technical Barriers [51.45596445363302]
  GlobeReady is a clinician-friendly AI platform that enables fundus disease diagnosis without retraining, fine-tuning, or the needs for technical expertise.<n>We demonstrate high accuracy across imaging modalities: 93.9-98.5% for 11 fundus diseases using color fundus photographs (CPFs) and 87.2-92.7% for 15 fundus diseases using optic coherence tomography ( OCT) scans.<n>By leveraging training-free local feature augmentation, GlobeReady platform effectively mitigates domain shifts across centers and populations.
  arXiv  Detail & Related papers  (2025-04-22T14:17:22Z)
• Development and prospective validation of a prostate cancer detection, grading, and workflow optimization system at an academic medical center [1.9729379339863824]
  We developed models for cancer detection, grading, and screening of cases for IHC ordering.<n>We compared the performance of task-specific prostate models with general-purpose foundation models.<n>No statistically significant differences were observed between task-specific and foundation models in cancer detection.
  arXiv  Detail & Related papers  (2024-10-31T05:29:18Z)
• Multi-institutional Validation of Two-Streamed Deep Learning Method for Automated Delineation of Esophageal Gross Tumor Volume using planning-CT and FDG-PETCT [14.312659667401302]
  Current clinical workflow for esophageal gross tumor volume (GTV) contouring relies on manual delineation of high labor-costs and interuser variability. To validate the clinical applicability of a deep learning (DL) multi-modality esophageal GTV contouring model, developed at 1 institution whereas tested at multiple ones.
  arXiv  Detail & Related papers  (2021-10-11T13:56:09Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.